Prophet Premium Blends recalls Diamond Shruumz products because the products contain Muscimol

The FDA reported that Prophet Premium Blends (Santa Ana, California) recalled Diamond Shruumz Infused Cones, Chocolate Bars, and Gummies (Micro- and Mega/Extreme-Dose) because such products contain Muscimol, a chemical found in mushrooms of the genus Amanita; Muscimol could be a potential cause of symptoms consistent with those observed in persons who became ill after eating Diamond Shruumz products. The products were distributed nationwide through retail stores and mail orders. All lots or best buy dates and all flavors of Diamond Shruumz Infused Cones, Chocolate Bars, and Gummies (Micro- and Mega/Extreme-Dose) are included in the recall. There are currently 39 illnesses that have been reported by June 27, 2024. States with cases include AL, AZ, CA, CO, GA, IN, IA, KY, MD, MN, MO, MT, NV, NJ, NY, NC, OH, PA, SC, and TN. Reported symptoms have included those linked to central nervous system excitation (e.g., seizures, agitation, and involuntary muscle contractions), central nervous system depression (e.g., loss of consciousness, confusion, and sleepiness), gastrointestinal symptoms (e.g., nausea and vomiting), and cardiovascular involvement (e.g., abnormal heart rates and hyper/hypotension). Prophet Premium Blends received two complaints (on May 27, 2024) regarding consumers becoming ill after consuming the chocolate bar. Prophet Premium Blends initiated this recall and has ceased the production and distribution of the Diamond Shruumz product line as the FDA and Prophet Premium Blends continue investigating the cause of the serious adverse effects. Retailers and wholesalers should discontinue use, stop distribution, quarantine the product immediately, and contact their sales representatives to initiate the return and refund.  @ https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/prophet-premium-blends-recalls-diamond-shruumz-products-because-possible-health-risk?utm_medium=email&utm_source=govdelivery

 

 

No comments

Leave a Reply